Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease	Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, X-linked disease, chronic granulomatous disease, granulomatous disease, chronic, X-linked, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, leukocyte disorder, phagocyte bactericidal dysfunction	Active, not recruiting	Phase 1 / Phase 2	2026-08-21		NCT06876363

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Ensoma	2

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Boston Children's Hospital	Boston	United States	343
Columbia University Irving Medical Center, Morgan Stanley Children's Hospital	New York	United States	1
Duke University	Durham	United States	160
Johns Hopkins All Children's Hospital	St. Petersburg	United States	116
University College London Hospital	London	United Kingdom	19
University of California, Los Angeles	Los Angeles	United States	142
University of California, San Francisco	San Francisco	United States	72
University of Minnesota	Minneapolis	United States	30
University of Utah, Primary Children's Hospital	Salt Lake City	United States	1